Neurones S.A. (EPA:NRO)

Neurones Statistics

Total Valuation

Neurones has a market cap or net worth of EUR 1.03 billion. The enterprise value is 846.55 million.

Market Cap	1.03B
Enterprise Value	846.55M

Important Dates

The next estimated earnings date is Wednesday, March 11, 2026.

Earnings Date	Mar 11, 2026
Ex-Dividend Date	Jun 11, 2025

Share Statistics

Neurones has 24.31 million shares outstanding. The number of shares has increased by 0.08% in one year.

Current Share Class	24.31M
Shares Outstanding	24.31M
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	4.41%
Owned by Institutions (%)	10.39%
Float	12.07M

Valuation Ratios

The trailing PE ratio is 20.43 and the forward PE ratio is 20.37.

PE Ratio	20.43
Forward PE	20.37
PS Ratio	1.24
PB Ratio	2.39
P/TBV Ratio	3.35
P/FCF Ratio	15.57
P/OCF Ratio	13.26
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.19, with an EV/FCF ratio of 12.76.

EV / Earnings	16.68
EV / Sales	1.02
EV / EBITDA	9.19
EV / EBIT	11.46
EV / FCF	12.76

Financial Position

The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.10.

Current Ratio	2.31
Quick Ratio	2.24
Debt / Equity	0.10
Debt / EBITDA	0.45
Debt / FCF	0.62
Interest Coverage	32.86

Financial Efficiency

Return on equity (ROE) is 14.64% and return on invested capital (ROIC) is 10.05%.

Return on Equity (ROE)	14.64%
Return on Assets (ROA)	6.61%
Return on Invested Capital (ROIC)	10.05%
Return on Capital Employed (ROCE)	15.75%
Revenue Per Employee	115,774
Profits Per Employee	7,059
Employee Count	7,087
Asset Turnover	1.19
Inventory Turnover	415.97

Taxes

In the past 12 months, Neurones has paid 23.41 million in taxes.

Income Tax	23.41M
Effective Tax Rate	27.80%

Stock Price Statistics

The stock price has decreased by -7.39% in the last 52 weeks. The beta is 0.60, so Neurones's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-7.39%
50-Day Moving Average	39.57
200-Day Moving Average	44.41
Relative Strength Index (RSI)	74.65
Average Volume (20 Days)	7,931

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Neurones had revenue of EUR 832.18 million and earned 50.74 million in profits. Earnings per share was 2.08.

Revenue	832.18M
Gross Profit	401.23M
Operating Income	73.90M
Pretax Income	84.21M
Net Income	50.74M
EBITDA	83.43M
EBIT	73.90M
Earnings Per Share (EPS)	2.08

Balance Sheet

The company has 288.70 million in cash and 41.47 million in debt, giving a net cash position of 247.23 million or 10.17 per share.

Cash & Cash Equivalents	288.70M
Total Debt	41.47M
Net Cash	247.23M
Net Cash Per Share	10.17
Equity (Book Value)	431.66M
Book Value Per Share	15.29
Working Capital	326.18M

Cash Flow

In the last 12 months, operating cash flow was 77.95 million and capital expenditures -11.59 million, giving a free cash flow of 66.36 million.

Operating Cash Flow	77.95M
Capital Expenditures	-11.59M
Free Cash Flow	66.36M
FCF Per Share	2.73

Margins

Gross margin is 48.21%, with operating and profit margins of 8.88% and 6.10%.

Gross Margin	48.21%
Operating Margin	8.88%
Pretax Margin	10.12%
Profit Margin	6.10%
EBITDA Margin	10.03%
EBIT Margin	8.88%
FCF Margin	7.97%

Dividends & Yields

This stock pays an annual dividend of 1.30, which amounts to a dividend yield of 3.06%.

Dividend Per Share	1.30
Dividend Yield	3.06%
Dividend Growth (YoY)	8.33%
Years of Dividend Growth	2
Payout Ratio	62.33%
Buyback Yield	-0.08%
Shareholder Yield	2.97%
Earnings Yield	4.91%
FCF Yield	6.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Neurones has an Altman Z-Score of 4.39 and a Piotroski F-Score of 6.

Altman Z-Score	4.39
Piotroski F-Score	6